Working Hours

MONDAY
8.00 – 19.30
TUESDAY
8.00 – 19.30

WEDNESDAY

8.00 – 19.30

THURSDAY

8.00 – 19.30

FRIDAY

8.00 – 19.30

SATURDAY

Closed

SUNDAY

Closed
doctor

Doctors

  • Pediatric
  • Dermatology
  • Ophthalmology
  • Gynecologic
  • Otolaryngology
hospital

Hospital

  • Camden, 200 Banning
  • Acres, 200 E Wyoming
  • Woods Manor, 199 South St
  • Anneville, 189 S Fairfield Dr
  • Kent Acres, 60 Wolf Creek Blvd
ambulance

Emergency

  • Camden: (405) 555-0128
  • Highland Acres: (671) 555-0110
  • Woods Manor: (307) 555-0133
  • Anneville: (219) 555-0114
  • Kent Acres: (219) 555-0114
Untitled-6

Therapies as individual as those who need them.

Lipo-ImmunoTech was founded on the goal of advancing anti-cancer strategies and/or neurodegenerative diseases that have strong mechanistic data and can dramatically benefit patient health.
Treatment of Alzheimer’s Disease and ALS
Immunotherapy
Cancer chemotherapy

Immuno Tech

Lipo-ImmunoTech is a spin-off company from the Medical University of South Carolina. Founders Dr. Ogretmen and Mehrotra are field-leading scientists, who maintain NIH-funded laboratories and active publications in top journals. Our research space is located at the Hollings Cancer Center and directly overseen by Drs. Ogretmen and Mehrotra. Our medical director, Dr. Lilly, is a physician scientist, who is one of the leading oncologists at the Hollings Cancer Center with national and international reputation.

rnd-rwc-hero

We hold the technology to make individualized oncology therapies a reality

Our company offers innovation in anti-cancer strategies utilizing lipid metabolism/signaling and immuno-therapy. Both pathways for treatment provides two-prong approach for attacking cancer through novel chemotherapeutics.

Cell Reports

Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response.

Blood

Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML.

Science Advances

Mitochondrial protein import is regulated by p17/PERMIT to mediate lipid metabolism and cellular stress.

Cell Metabolism

Heightened effector function and prolonged persistence, the key attributes of Th1 and Th17 cells are key features.

Current Therapies in Development

Cancer-specific Ceramide analogues

• Novel chemotherapeutic not traditionally targeted for therapy
• Attacks cancer cells through mitochondria
• Re-sensitization of cancer cells towards normal progression of cellular death
• Sphingolipid biology is a rising target for cancer treatment
• Multiple publications and early pre-clinical work already performed
• These compounds have indications to improve neurodegenerative disorders, such as Alzheimer’s Disease and ALS by improving mitochondrial quality control in neurons

Expansion of T cells for personalized tumor treatment

• Novel activation cocktail for T cell development from patient’s own T cells
• Complementary system for CAR T cell therapy
• T cell therapy that does not need active genetic manipulation
• Potential kit-based system for patient cells performed within own hospital
• Ready for clinical trials because of patient’s own cells involved in therapy without genetic manipulation

Who We Are

We are offering expertise and methodology for improving T cell-mediated immunotherapy, and insight into lipid signaling targets for various disease models.

Get In Touch

Lipo-ImmunoTech was founded on the goal of advancing anti-cancer strategies and/or neurodegenerative diseases that have strong mechanistic data and can dramatically benefit patient health.

Patient Reviews